Clinical Encounter - Administrative Note: DOJ-OGR-00026234
On July 12, 2019, Jeffrey Epstein requested a change in his constipation medication from Bisacodyl to Docusate Sodium (Colace). The change was approved and processed by a medical provider at the Metropolitan Correctional Center in New York (NYM).
Summary
On July 12, 2019, Jeffrey Epstein requested a change in his constipation medication from Bisacodyl to Docusate Sodium (Colace). The change was approved and processed by a medical provider at the Metropolitan Correctional Center in New York (NYM).
This document is from the epstein-docs Archive.
View Source CollectionPersons Referenced (1)
Related Documents (6)
EFTA01682184
EFTA01370863
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
EFTA00014087
EFTA02367961
EFTA01977826
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.